Video

Biosimilars in Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.

Related Videos
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Related Content
Precision medicine in neurology -- Image credit: Evon J | stock.adobe.com
April 9th 2025

AAN 2025: Precision Medicine and Pharmacogenomics in Neurological Care

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Syringe and vial labeled GLP 1 are prominently displayed, symbolizing medical advancements and treatments. background features blurred, colorful pattern, enhancing focus on medical items - Image credit: mingnimit | stock.adobe.com
April 9th 2025

Expert Q&A: Exploring the Role of GLP-1 Receptor Agonists in Diabetes Management

Kennedy Ferruggia, Assistant Editor Elaina Rosario, PharmD, CPh, BCACP, CDCES
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Platelets forming a blood clot, AI Generative
April 4th 2025

Fitusiran Maintains Long-Term Bleeding Control in Hemophilia A or B, With or Without Inhibitors

Luke Halpern, Assistant Editor
FDA headquarters sign -- Image credit: JHVEPhoto | stock.adobe.com
April 3rd 2025

FDA Approves Inebilizumab to Treat Adult Patients With IgG4-RD

Gillian McGovern, Associate Editor